# Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis

> **NCT06099626** · — · UNKNOWN · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Autoimmune Liver Disease, COVID-19

## Interventions

- **OTHER:** Different types of disease

## Key facts

- **NCT ID:** NCT06099626
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099626, "Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06099626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*